Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer’s Disease and Other Neurodegenerative Disorders

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events

(2015) Kaj Blennow et al.   Frontiers in Neuroscience

Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance

(2012) A. Durukan Tolvanen et al.   NEUROSCIENCE

Evolution and roles of stanniocalcin

(2011) B.H.Y. Yeung et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease

(2010) Christiane Reitz et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies

(2008) Fredrik Boström et al.   NEUROBIOLOGY OF AGING